Suppr超能文献

惊恐障碍:治疗进展

Panic disorder: a treatment update.

作者信息

Burrows G D, Norman T R, Judd F K

机构信息

Department of Psychiatry, University of Melbourne, Austin Hospital, Victoria, Australia.

出版信息

J Clin Psychiatry. 1991 Jul;52 Suppl:24-6.

PMID:2071568
Abstract

Panic disorder is characterized by unexpected, unprovoked attacks of cognitive symptoms (e.g., dread, fear) and physical symptoms (e.g., palpitations, trembling, shortness of breath). It is the most common anxiety disorder seen in clinical practice. Pharmacotherapy has been shown to be effective in controlling symptoms of panic disorder, although potential disadvantages (e.g., adverse drug reactions, withdrawal syndrome, dependency) must be carefully assessed and balanced against the advantages. Current data indicate that for panic disorder, benzodiazepines prescribed for more than a 6-month period are as effective as other forms of pharmacotherapy, i.e., monoamine oxidase inhibitors and tricyclic antidepressants. Generally, doses of benzodiazepines used for the treatment of panic are higher compared to those used for generalized anxiety disorder.

摘要

惊恐障碍的特征是出现意想不到的、无端的认知症状(如恐惧、害怕)和身体症状(如心悸、颤抖、呼吸急促)发作。它是临床实践中最常见的焦虑障碍。药物治疗已被证明对控制惊恐障碍的症状有效,尽管必须仔细评估潜在的缺点(如药物不良反应、戒断综合征、依赖性),并与优点相权衡。目前的数据表明,对于惊恐障碍,开具超过6个月的苯二氮䓬类药物与其他形式的药物治疗(即单胺氧化酶抑制剂和三环类抗抑郁药)效果相同。一般来说,用于治疗惊恐的苯二氮䓬类药物剂量比用于广泛性焦虑障碍的剂量更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验